We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
Cap. Flow
+$324M
Cap. Flow %
2.32%
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391

Top Buys

Rank Stock Value
1
MUB icon
iShares National Muni Bond ETF
MUB
+$176M
2
INFY icon
Infosys
INFY
+$102M
3
K
Kellanova
K
+$74.6M
4
AMZN icon
Amazon
AMZN
+$58.6M
5
BABA icon
Alibaba
BABA
+$52.5M

Sector Composition

Rank Sector Weight
1 Technology 10.38%
2 Financials 4.13%
3 Consumer Discretionary 2.33%
4 Communication Services 2.26%
5 Healthcare 2.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
676
PUT
Monster Beverage
MNST
$93.2B
$1.39M 0.01%
22,200
+7,300
+49% +$446K
MRNA icon
677
CALL
Moderna
MRNA
$22.1B
$1.38M 0.01%
50,000
-40,200
-45% -$1.06M
NNAVW
678
DELISTED
NextNav Inc Warrant
NNAVW
$1.37M 0.01%
216,367
HTZ icon
679
PUT
Hertz
HTZ
$632M
$1.37M 0.01%
+200,000
New +$1.25M
ALT icon
680
PUT
Altimmune
ALT
$576M
$1.37M 0.01%
+352,800
New +$1.91M
UAL icon
681
United Airlines
UAL
$39.1B
$1.36M 0.01%
17,060
+10,705
+168% +$789K
NCLH icon
682
Norwegian Cruise Line
NCLH
$9.2B
$1.35M 0.01%
66,621
-7,892
-11% -$141K
NAK
683
CALL
Northern Dynasty Minerals
NAK
$857M
$1.34M 0.01%
+1,000,000
New +$1.12M
DJT icon
684
PUT
Trump Media & Technology Group
DJT
$2.65B
$1.33M 0.01%
+73,700
New +$1.6M
AUROW
685
Aurora Innovation Warrant
AUROW
$388M
$1.33M 0.01%
1,526,041
-35,460
-2% -$43.6K
VKTX icon
686
CALL
Viking Therapeutics
VKTX
$4.05B
$1.32M 0.01%
50,000
ELV icon
687
CALL
Elevance Health
ELV
$82.1B
$1.32M 0.01%
3,400
+2,500
+278% +$1.01M
DE icon
688
PUT
Deere & Co
DE
$169B
$1.32M 0.01%
2,600
-4,500
-63% -$2.2M
NCLH icon
689
CALL
Norwegian Cruise Line
NCLH
$9.2B
$1.32M 0.01%
65,000
-144,600
-69% -$2.59M
DKNG icon
690
CALL
DraftKings
DKNG
$12B
$1.31M 0.01%
30,600
-29,800
-49% -$1.07M
MELI icon
691
CALL
Mercado Libre
MELI
$92.3B
$1.31M 0.01%
500
-2,600
-84% -$6.07M
SRPT icon
692
CALL
Sarepta Therapeutics
SRPT
$1.68B
$1.3M 0.01%
+75,800
New +$3.23M
UNIT
693
CALL
Uniti Group
UNIT
$2.62B
$1.3M 0.01%
+300,000
New +$1.35M
SW
694
Smurfit Westrock
SW
$26.3B
$1.29M 0.01%
30,000
-71,840
-71% -$3.07M
SRRK icon
695
CALL
Scholar Rock
SRRK
$5.86B
$1.29M 0.01%
+36,400
New +$1.14M
MTCH icon
696
PUT
Match Group
MTCH
$9.05B
$1.29M 0.01%
41,600
-90,400
-68% -$2.7M
MURA
697
DELISTED
Mural Oncology
MURA
$1.28M 0.01%
+516,417
New +$1.22M
SHLS icon
698
CALL
Shoals Technologies Group
SHLS
$1.57B
$1.27M 0.01%
+300,000
New +$1.3M
NTR icon
699
CALL
Nutrien
NTR
$32.4B
$1.26M 0.01%
21,600
+8,700
+67% +$492K
GSK icon
700
PUT
GSK
GSK
$104B
$1.26M 0.01%
+32,700
New +$1.25M

Similar funds

LMR Partners's Q2 2025 Portfolio in Review

As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
  • LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
  • LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
  • LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
  • LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
  • LMR Partners opened 418 new positions and closed 391 in Q2 2025.
  • LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.

Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.